Cargando…

Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein

Basigin, or CD147, has been reported as a coreceptor used by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to invade host cells. Basigin also has a well-established role in Plasmodium falciparum malaria infection of human erythrocytes, where it is bound by one of the parasite’s invasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ragotte, Robert J., Pulido, David, Donnellan, Francesca R., Hill, Michelle L., Gorini, Giacomo, Davies, Hannah, Brun, Juliane, McHugh, Kirsty, King, Lloyd D. W., Skinner, Katherine, Miura, Kazutoyo, Long, Carole A., Zitzmann, Nicole, Draper, Simon J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386461/
https://www.ncbi.nlm.nih.gov/pubmed/34378982
http://dx.doi.org/10.1128/mSphere.00647-21
_version_ 1783742267398291456
author Ragotte, Robert J.
Pulido, David
Donnellan, Francesca R.
Hill, Michelle L.
Gorini, Giacomo
Davies, Hannah
Brun, Juliane
McHugh, Kirsty
King, Lloyd D. W.
Skinner, Katherine
Miura, Kazutoyo
Long, Carole A.
Zitzmann, Nicole
Draper, Simon J.
author_facet Ragotte, Robert J.
Pulido, David
Donnellan, Francesca R.
Hill, Michelle L.
Gorini, Giacomo
Davies, Hannah
Brun, Juliane
McHugh, Kirsty
King, Lloyd D. W.
Skinner, Katherine
Miura, Kazutoyo
Long, Carole A.
Zitzmann, Nicole
Draper, Simon J.
author_sort Ragotte, Robert J.
collection PubMed
description Basigin, or CD147, has been reported as a coreceptor used by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to invade host cells. Basigin also has a well-established role in Plasmodium falciparum malaria infection of human erythrocytes, where it is bound by one of the parasite’s invasion ligands, reticulocyte binding protein homolog 5 (RH5). Here, we sought to validate the claim that the receptor binding domain (RBD) of SARS-CoV-2 spike glycoprotein can form a complex with basigin, using RH5-basigin as a positive control. Using recombinantly expressed proteins, size exclusion chromatography and surface plasmon resonance, we show that neither RBD nor full-length spike glycoprotein bind to recombinant human basigin (expressed in either Escherichia coli or mammalian cells). Further, polyclonal anti-basigin IgG did not block SARS-CoV-2 infection of Vero E6 cells. Given the immense interest in SARS-CoV-2 therapeutic targets to improve treatment options for those who become seriously ill with coronavirus disease 2019 (COVID-19), we would caution the inclusion of basigin in this list on the basis of its reported direct interaction with SARS-CoV-2 spike glycoprotein. IMPORTANCE Reducing the mortality and morbidity associated with COVID-19 remains a global health priority. Vaccines have proven highly effective at preventing infection and hospitalization, but efforts must continue to improve treatment options for those who still become seriously ill. Critical to these efforts is the identification of host factors that are essential to viral entry and replication. Basigin, or CD147, was previously identified as a possible therapeutic target based on the observation that it may act as a coreceptor for SARS-CoV-2, binding to the receptor binding domain of the spike protein. Here, we show that there is no direct interaction between the RBD and basigin, casting doubt on its role as a coreceptor and plausibility as a therapeutic target.
format Online
Article
Text
id pubmed-8386461
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-83864612021-09-09 Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein Ragotte, Robert J. Pulido, David Donnellan, Francesca R. Hill, Michelle L. Gorini, Giacomo Davies, Hannah Brun, Juliane McHugh, Kirsty King, Lloyd D. W. Skinner, Katherine Miura, Kazutoyo Long, Carole A. Zitzmann, Nicole Draper, Simon J. mSphere Research Article Basigin, or CD147, has been reported as a coreceptor used by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to invade host cells. Basigin also has a well-established role in Plasmodium falciparum malaria infection of human erythrocytes, where it is bound by one of the parasite’s invasion ligands, reticulocyte binding protein homolog 5 (RH5). Here, we sought to validate the claim that the receptor binding domain (RBD) of SARS-CoV-2 spike glycoprotein can form a complex with basigin, using RH5-basigin as a positive control. Using recombinantly expressed proteins, size exclusion chromatography and surface plasmon resonance, we show that neither RBD nor full-length spike glycoprotein bind to recombinant human basigin (expressed in either Escherichia coli or mammalian cells). Further, polyclonal anti-basigin IgG did not block SARS-CoV-2 infection of Vero E6 cells. Given the immense interest in SARS-CoV-2 therapeutic targets to improve treatment options for those who become seriously ill with coronavirus disease 2019 (COVID-19), we would caution the inclusion of basigin in this list on the basis of its reported direct interaction with SARS-CoV-2 spike glycoprotein. IMPORTANCE Reducing the mortality and morbidity associated with COVID-19 remains a global health priority. Vaccines have proven highly effective at preventing infection and hospitalization, but efforts must continue to improve treatment options for those who still become seriously ill. Critical to these efforts is the identification of host factors that are essential to viral entry and replication. Basigin, or CD147, was previously identified as a possible therapeutic target based on the observation that it may act as a coreceptor for SARS-CoV-2, binding to the receptor binding domain of the spike protein. Here, we show that there is no direct interaction between the RBD and basigin, casting doubt on its role as a coreceptor and plausibility as a therapeutic target. American Society for Microbiology 2021-08-11 /pmc/articles/PMC8386461/ /pubmed/34378982 http://dx.doi.org/10.1128/mSphere.00647-21 Text en Copyright © 2021 Ragotte et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Ragotte, Robert J.
Pulido, David
Donnellan, Francesca R.
Hill, Michelle L.
Gorini, Giacomo
Davies, Hannah
Brun, Juliane
McHugh, Kirsty
King, Lloyd D. W.
Skinner, Katherine
Miura, Kazutoyo
Long, Carole A.
Zitzmann, Nicole
Draper, Simon J.
Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein
title Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein
title_full Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein
title_fullStr Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein
title_full_unstemmed Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein
title_short Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein
title_sort human basigin (cd147) does not directly interact with sars-cov-2 spike glycoprotein
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386461/
https://www.ncbi.nlm.nih.gov/pubmed/34378982
http://dx.doi.org/10.1128/mSphere.00647-21
work_keys_str_mv AT ragotterobertj humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein
AT pulidodavid humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein
AT donnellanfrancescar humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein
AT hillmichellel humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein
AT gorinigiacomo humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein
AT davieshannah humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein
AT brunjuliane humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein
AT mchughkirsty humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein
AT kinglloyddw humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein
AT skinnerkatherine humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein
AT miurakazutoyo humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein
AT longcarolea humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein
AT zitzmannnicole humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein
AT drapersimonj humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein